Liraglutide
Explore peptide research and guides on liraglutide.
Liraglutide
Liraglutide for Adolescent Obesity: The Pediatric Evidence
FDA-approved liraglutide reduced BMI by 4.6% more than placebo in obese adolescents. Review of all pediatric trials, safety data, and who responds best.
LiraglutideLiraglutide Long-Term Safety Data
What the LEADER trial and 10+ years of real-world data show about liraglutide's cardiovascular benefits, thyroid cancer signal, pancreatitis risk, and GI side effects.
LiraglutideLiraglutide vs Semaglutide Compared
STEP 8 trial: semaglutide produced 15.8% weight loss vs 6.4% for liraglutide. Head-to-head comparison of efficacy, dosing, cost, and cardiovascular data.